(E)-4,4,5,5-tetramethyl-2-(2-(tetrahydro-2H-pyran-4-yl)vinyl)-1,3,2-dioxaborolane

Catalog No. :
ACLOEG603
CAS No. :
2407873-38-3
Molecular Formula :
C13H23BO3
Molecular Weight :
238.17

IUPAC Name:(E)-4,4,5,5-tetramethyl-2-(2-(tetrahydro-2H-pyran-4-yl)vinyl)-1,3,2-dioxaborolane

(E)-4,4,5,5-tetramethyl-2-(2-(tetrahydro-2H-pyran-4-yl)vinyl)-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$799.00Login to see priceInquiryInquiry
100mg97%$1228.00Login to see priceInquiryInquiry
250mg97%$2363.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-4,4,5,5-tetramethyl-2-(2-(tetrahydro-2H-pyran-4-yl)vinyl)-1,3,2-dioxaborolane
IUPAC Name(E)-4,4,5,5-tetramethyl-2-(2-(tetrahydro-2H-pyran-4-yl)vinyl)-1,3,2-dioxaborolane
MDL No.0
Molecular FormulaC13H23BO3
Molecular Weight238.17
SMILESCC(C)(C(C)(O1)C)OB1/C=C/C2CCOCC2
InChI KeyXNDFSDONEUAXBI-VMPITWQZSA-N
CAS No.2407873-38-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLOEG603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLOEG603 route product structure diagram
    ACLOEG6032407873-38-3
Inquiry

2. ACLOEG603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGLQZ506 route compound structure diagram
    ACGLQZ50650675-18-8 In Stock
  4. Then
  5. ACLOEG603 route product structure diagram
    ACLOEG6032407873-38-3
Inquiry

Comments (0)